Keeping Our Community Healthy
Since the start of the COVID-19 pandemic, Berklee has been committed to keeping our community safe and informed. We implemented robust safety protocols to effectively protect the health of our community and keep our COVID-19 infection rate low.
Health and Safety Protocols
We continue to develop our plans in partnership with Tufts Medical Center, along with guidance from state and local authorities. Please note that this information is subject to change, and the community will be notified of any changes accordingly.
Learn about our current protocols:
- COVID-19 vaccination and booster requirement: All community members—students, faculty, staff, and vendor partners—at Berklee’s Boston campus are required to receive the full COVID-19 vaccination series, including a booster shot, unless they have obtained an approved medical or religious vaccination exemption.
- Masks: Masks are optional on the Boston campus.
- Testing: Students who are experiencing COVID-19 symptoms may get a rapid antigen test at the Berklee Testing Center.
- Quarantine and isolation: Berklee requires that community members who test positive for COVID-19 self-isolate for a period of five days regardless of previous infection, vaccination or booster status, and the presence or absence of symptoms. Instructions for isolation will be provided upon submitting your positive test result using this form.
- Event and performance policies: There are no vaccination, testing, or masking requirements for event attendees.
COVID-19 symptoms: If you experience any COVID-19 symptoms, call the Berklee COVID-19 Testing Center (617-747-2019, option 1) for guidance.
Non-COVID-19 urgent/primary care: Tufts Medical Center, our preferred medical provider, serves currently enrolled Berklee College of Music and Boston Conservatory at Berklee students. If you experience medical symptoms unrelated to COVID-19, call the dedicated Berklee phone number at Tufts (617-636-6006) for an appointment. The preferred access specialist will ask you basic questions and then schedule an appointment at Tufts if appropriate. A round-trip ride to/from campus will also be coordinated at no charge. It is highly recommended that you select a Tufts primary care provider to ensure continuity of care during your time at Berklee.
Learn about how to access medical care for students, including telehealth, through Tufts Medical Center.
Faculty and Staff
Contact your primary health care provider.
State and Greater Boston Area Health Guidelines
The Boston Public Health Commission has comprehensive information on the city of Boston COVID-19 website about efforts to minimize the spread of COVID-19. For information on statewide initiatives, visit Mass.gov.
If you are at an increased risk of severe illness if you contract COVID-19, contact your physician to assess the risks of living and/or studying on campus. For more information, or to request accommodations, please contact firstname.lastname@example.org.
Faculty and Staff
If a faculty or staff member’s health condition falls within one of the CDC's high-risk categories, as described in the CDC guidelines, the employee may seek a temporary COVID-19 workplace accommodation through Human Resources. Please follow Berklee’s reasonable accommodation process. Employees are not required to disclose if they are in a high-risk category based upon age or a pre-existing medical condition. If an employee voluntarily discloses any medical information, it will be handled with the highest degree of sensitivity and confidentiality.
Various options that support a healthy and safe work environment will be considered. Continued remote work arrangements with periodic reviews of return-to-campus dates may be provided.
CDC Travel Guidance
Visit the Centers for Disease Control and Prevention (CDC) site for information on how to travel safely to and from the U.S., including details on potential mask and vaccination mandates.
COVID-19 Test Results Dashboard
Berklee maintained a community-wide mandatory asymptomatic testing program using PCR tests from January 2021 through March 2022. As of March 26, after transitioning away from surveillance testing toward symptomatic-only testing, we stopped publishing testing data on the public dashboard.